Assessment of Plasmodium Vivax Chloroquine Resistance in Cambodia:

NCT02118090 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Vivax Malaria

Interventions

DRUG: Chloroquine sulfate
DRUG: DHA-PP

Sponsor

Institut Pasteur, Cambodia

Collaborators

[object Object]